Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

NCT02017444 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Intracranial Hypertension

Interventions

DRUG: AZD4017
OTHER: Placebo

Sponsor

University of Birmingham